Related Experiment Videos
Isoniazid-induced pure red cell aplasia
The American Journal of the Medical Sciences
|July 1, 1983
Summary
Isoniazid, a tuberculosis drug, can cause a reversible form of pure red cell aplasia. Stopping the medication resolves this condition, highlighting drug-induced blood disorders.
Area of Science:
- Hematology
- Pharmacology
- Internal Medicine
Background:
- Isoniazid is a primary antitubercular medication.
- Drug-induced cytopenias are a concern in clinical practice.
- Pure red cell aplasia (PRCA) is a rare disorder characterized by absent erythroid precursors.
Observation:
- Four patients developed pure red cell aplasia (PRCA) during isoniazid therapy.
- Erythroblastopenia resolved in all patients after discontinuing isoniazid.
- In vitro studies using clonal assays did not demonstrate direct inhibition of erythroid precursors by isoniazid.
Findings:
- Isoniazid use is associated with a reversible form of acquired PRCA.
- The exact mechanism of isoniazid-induced PRCA remains unclear.
- In vitro bone marrow culture systems may have limitations in identifying drug-induced cytopenias.
Implications:
- Clinicians should consider isoniazid as a potential cause of PRCA.
- Prompt cessation of isoniazid can lead to recovery of red blood cell production.
- Further research is needed to elucidate the pathogenesis of drug-induced PRCA.